| Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | ||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
-16,392 | -8,386 | -6,022 | -8,096 | -14,358 | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Depreciation and amortization | ||||||
86 | 81 | 66 | 68 | 61 | ||
Non-cash share-based compensation | ||||||
1,734 | 1,175 | 959 | 1,211 | 836 | ||
Accretion on marketable securities | ||||||
537 | - | - | - | - | ||
Deferred taxes | ||||||
-44 | - | - | - | - | ||
Unrealized foreign currency (gains) losses | ||||||
136 | 546 | -1,814 | 6,166 | -4,509 | ||
Realized investment (gains) losses | ||||||
1,110 | - | - | - | - | ||
Changes in operating assets and liabilities: | ||||||
Research and development tax credit receivable | ||||||
392 | - | - | - | 1,382 | ||
Prepaid expenses and other assets | ||||||
-893 | 80 | 1,953 | 2,131 | -908 | ||
Accounts payable | ||||||
16 | -1,385 | 1,172 | -1,561 | 1,765 | ||
Accrued expenses and other liabilities | ||||||
4,520 | 1,900 | 1,717 | 3,277 | -1,261 | ||
Net cash used in operating activities | ||||||
-11,362 | -16,974 | -4,501 | -15,235 | -8,922 | ||
Cash flows from investing activities: | ||||||
Proceeds from maturities of marketable securities | ||||||
78,000 | - | - | - | - | ||
Purchases of property and equipment | ||||||
14 | 322 | 224 | 120 | 43 | ||
Net cash provided by (used in) investing activities | ||||||
77,986 | -81,238 | 14,984 | -69,702 | -43 | ||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | ||||||
105 | 2,858 | -6,084 | 4,293 | 1,838 | ||
Net increase (decrease) in cash, cash equivalents and restricted cash | ||||||
66,729 | -18,190 | 4,398 | -80,643 | -7,127 | ||